COMMUNIQUÉS West-GlobeNewswire

Aardvark Therapeutics to Present at the Stifel 2025 Virtual Cardiometabolic Forum
23/09/2025
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate [...]
LifeMD Declares Quarterly Dividend on Series A Cumulative Perpetual Preferred Stock
23/09/2025
NEW YORK, Sept. 23, 2025 (GLOBE NEWSWIRE) -- LifeMD, Inc. (Nasdaq: LFMD), a leading provider of virtual primary care services, today announced that its Board of Directors has authorized a cash dividend to holders of the [...]
Privia Health Expands Value-Based Care Footprint with Acquisition of Accountable Care Organization Business from Evolent Health
23/09/2025
ARLINGTON, Va., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) announced that it signed a definitive agreement to acquire an Accountable Care Organization (ACO) business from Evolent Health [...]
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient
23/09/2025
Nyxoah Présente les Dernières Avancées Concernant son Expansion au Moyen-Orient De nouveaux centres à Dubaï, au Koweït et à Abu Dhabi après la première implantation de Genio® dans la région au début de l'année 2025 Mont [...]
Nyxoah Provides an Update on Expanded Middle East Presence
23/09/2025
Nyxoah Provides an Update on Expanded Middle East Presence New Centers in Dubai, Kuwait, and Abu Dhabi Following First Genio® Implant in the Region Earlier in 2025 Mont-Saint-Guibert, Belgium – September 23, 2025, 10: [...]
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes
23/09/2025
OSE Immunotherapeutics prend acte de la décision du Tribunal de commerce de Nantes NANTES, France – 23 septembre 2025, 22 h 30 – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) prend acte de la décision [...]
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court
23/09/2025
OSE Immunotherapeutics acknowledges the decision of the Nantes Commercial Court NANTES, France – September 23, 2025, 10:30 p.m. CET – OSE Immunotherapeutics SA (ISIN: FR0012127173; Mnemo: OSE) acknowledges the decision [...]
Natural Alternatives International, Inc. Announces Fiscal 2025 Q4 and YTD Results
23/09/2025
CARLSBAD, Calif., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Natural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today [...]
Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
23/09/2025
CAMBRIDGE, Mass., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) today announced that the U.S. Food and Drug Administration (FDA) issued a Complete Response Letter (CRL) for the Company’s supplemental New [...]
Lifecore Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
23/09/2025
CHASKA, Minn., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”) a fully integrated contract development and manufacturing organization (“CDMO”), today announced that on September [...]
Appili Therapeutics Announces Results of Annual and Special Meeting of Shareholders
23/09/2025
HALIFAX, Nova Scotia, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Appili Therapeutics Inc. (TSX: APLI; OTCPink: APLIF) (the “ Company ” or “ Appili ”), a biopharmaceutical company focused on drug development for infectious [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 38 - 2025
23/09/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 15 Septembre au 19 Septembre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 38 - 2025
23/09/2025
Aggregated presentation by day and by market Statement of transactions in own shares from September 15th to September 19th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the [...]
Supplements For Testosterone Booster 2025: TestoPrime” Natural Testosterone Booster Supplement For Men 40 or 50 launch in USA.
23/09/2025
TestoPrime launch a Effective and Best Testosterone Booster Supplement For Men 40 or 50, this is most popular and natural Supplements For Testosterone Booster 2025 New York, Sept. 23, 2025 (GLOBE NEWSWIRE) -- NEW YORK, [...]
Dunham House Opens Applications for Residents
23/09/2025
OMAHA, Neb., Sept. 23, 2025 (GLOBE NEWSWIRE) -- Dunham House , a first-of-its-kind, transformational initiative for combat-wounded veterans in need of long-term residential-centered care for their wounds, has opened [...]
UPDATE - Shotsy Names Eric Perakslis as Chief Science Officer to Advance Safe, Science-Backed GLP-1 Support
23/09/2025
Internationally recognized researcher in medical safety and privacy, former CIO and Chief Scientist (Informatics) at the FDA, brings scientific and regulatory leadership to Shotsy. PORTLAND, Ore., Sept. 23, 2025 (GLOBE [...]
Mainz Biomed Announces Commercial Launch of ColoAlert® in Switzerland
23/09/2025
Company Provides Update on eAArly DETECT 2 Study BERKELEY, Calif. and MAINZ, Germany, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic [...]
IO Biotech Announces Late-Breaking Abstract in Advanced Melanoma Selected for Oral Presentation at ESMO Congress 2025
23/09/2025
Oral presentation will highlight the results from the randomized Phase 3 trial (IOB-013/KN-D18) of IO102-IO103 cancer vaccine plus pembrolizumab for first-line (1L) advanced melanoma Poster presentation will share final [...]
SeaStar Medical to Present Early SAVE Registry Data of QUELIMMUNE in Pediatric Acute Kidney Injury at the 5th International Symposium on Acute Kidney Injury in Children
23/09/2025
DENVER, Sept. 23, 2025 (GLOBE NEWSWIRE) -- SeaStar Medical Holding Corporation (Nasdaq: ICU), a commercial-stage healthcare company, announced today that preliminary results from the SAVE Surveillance Registry will be [...]

Pages